期刊文献+

含甘草酸效应组分微丸的制备及其性质考察 被引量:3

Preparation and properties of sustained-release pellets of glycyrrhizin effective components
下载PDF
导出
摘要 目的:应用挤出滚圆法制备含甘草酸效应组分速释微丸,采用Eudragit RS 100与Eudragi RL 1002种包衣材料,制备含甘草酸效应组分缓释微丸。方法:采用Mini Glatt流化床底喷包衣法制备缓释微丸,对其包衣工艺及处方进行单因素考察,评价微丸的粉体学性质和体外释放行为。结果:当Eudragit RS 100与Eudragit RL 100的质量比为4∶l,聚合物包衣增重为5%,增塑剂用量为15%时,药物具有明显的缓释作用,体外释放曲线符合Pep-pas和Higuchi方程。结论:通过调整Eudragit RS 100与Eudragit RL 100的比例,或提高聚合物包衣增重等手段,能使含甘草酸效应组分缓释微丸具备较理想的缓释效果。 Objective: To prepare the glycyrrhizin pellets by extrusion-spheronization, and optimize the formulation of sustained release pellets of glycyrrhizin effective components coated with mixed Eudragit RS 100 and Eudragit RL100. Method: The sustained-release pellets of glycyrrhizin were prepared by Glatt fluid bed technique. The ratio of Eudragit RS 100 to Eudragit RL 100 in the formulation was optimized. The factors that influence the drug release behaviors and their properties were evaluated. Result: The optimal coat for drug sustained-release was shown at the ratio of Eudragit RS 100 to Eudragit RL 100 of 4: 1, the loading weight of copolymers of 5% and the plasticizer concentration of 15%. The curves of cumulative drug release were fit for Peppas and Higuchi equation. Conclusion: The optimal sustained release of the glycyrrhizin effective component pellets is featured by adjusting the ratio of Eudragit RS 100 to Eudragit RL100 and the loading weight of copolymers.
出处 《中国中药杂志》 CAS CSCD 北大核心 2008年第5期509-513,共5页 China Journal of Chinese Materia Medica
基金 上海市重点学科建设项目(T0301) 上海市科委项目(04DZ19841) 高等学校博士学科点专项科研基金项目(20060268009)
关键词 含甘草酸效应组分 EUDRAGIT RS 100 EUDRAGIT RL 100 微丸 释放度 glycyrrhizin effective components Eudragit RS100 Eudragit RL 100 sustined release pellets
  • 相关文献

参考文献4

  • 1Shah V P, Tsong Y, Sathe P, et al. In vitro dissolution profile comparison-statistics and analysis of the similarity factors f2 [ J ]. Pharm Res, 1998,15(6) :889.
  • 2赵语,蒋学华,周天杰,杨春秀,赵劲松,程小宁,陈钧.用均匀设计法优选水溶性药物缓释片的制备工艺[J].华西药学杂志,2000,15(5):252-254. 被引量:15
  • 3Ritger R L, Peppas N A. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs [ J ]. J Control Release, 1987,5( 1 ) :23.
  • 4Kramar A, Vreeer F. Statistical optimization of dielofenac sustained release pellets coated with polymethacrylic films[ J]. Int J Pharm, 2003,256(10) :43.

二级参考文献2

共引文献14

同被引文献31

  • 1罗晓健,张国松,黄锋荣,饶小勇,何雁,胡鹏翼.流化床制备芪仙汤微丸的工艺研究[J].中国中药杂志,2009,34(6):690-693. 被引量:7
  • 2陈红霞,贾晓斌,陈彦,潘国梁,成旭东.挤出滚圆法制备复方杞芪微丸的处方及工艺优化[J].中国中药杂志,2006,31(22):1862-1865. 被引量:15
  • 3段伟奇,姬胜利.甘草酸抗病毒活性的研究进展[J].中草药,2007,38(4). 被引量:25
  • 4陆斌.药物新剂型与新技术[M].北京:人民卫生出版社,1998.24.
  • 5王晖,陈丽,陈垦,薛漫清,梁庆.多指标综合评价方法及权重系数的选择[J].广东药学院学报,2007,23(5):583-589. 被引量:262
  • 6陆彬.药物新剂型与新技术[M]北京:人民卫生出版社,2005448-463.
  • 7平其能.现代药剂学[M]北京:中国医药科技出版社,1998411.
  • 8Roblegg E,Ulbing S,Zeissmann S. Developmentof lipophilic calcium stearate pelletsusing ibuprofen asmodeldrug[J].European Journal of Pharmaceutics and Biopharmaceutics,2010,(01):56.doi:10.1016/j.ejpb.2010.01.005.
  • 9Lotlikar V,Kedar U,Shidhaye S. pH-responsive dual pulse multiparticulate dosage form for treatment of rheumatoid arthritis[J].Drug Development and Industrial Pharmacy,2010,(11):1295-1302.
  • 10Ahmed A,Martin B. Preparation and characterization of a selfemulsifying pellet formulation[J].European Journal of Pharmaceutics and Biopharmaceutics,2007,(02):220.doi:10.1016/j.ejpb.2006.11.015.

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部